A2 Milk (ASX:A2M) share price jumps 12% on 'improved' outlook

A2 Milk shares are rocketing higher today. Here's why…

| More on:
rising asx share price represented by happy woman dancing excitedly

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points

  • A2 Milk shares are rocketing higher after the release of its half year results
  • While it posted a very disappointing decline, investors appear optimistic on the future
  • Management expects a stronger second half than previously expected

The A2 Milk Company Ltd (ASX: A2M) share price is having an excellent start to the week.

In afternoon trade, the embattled infant formula company's shares are up 12% to $5.95.

Why is the A2 Milk share price racing higher?

Investors have been bidding the A2 Milk share price higher today following the release of its half year results.

In case you missed it, A2 Milk reported a 2.5% increase in revenue over the prior corresponding period to NZ$661 million. Though, this was driven by the inclusion of the Mataura Valley Milk (MVM) business, which wasn't part of the company in the prior corresponding period.

A better reflection on its performance during the half was that of its core infant nutrition business, which reported a 10.5% reduction in revenue to NZ$471 million. This was driven by the lower birth rate and rapidly changing market dynamics in China.

On the bottom line, things were even worse. A2 Milk reported a 53.3% decline in net profit after tax to NZ$56 million. This compares unfavourably to the market consensus estimate, which according to Commsec was NZ$60 million.

So why are its shares rising?

The catalyst for the rise in the A2 Milk share price today appears to have been its outlook.

Some upbeat commentary from management seems to have offset the profit miss and got investors excited.

A2 Milk's CEO, David Bortolussi, commented: "The Company's outlook for 2H22 revenue has improved. It is still expected to be significantly higher than 2H21, and with growth now expected on 1H22 and for FY22, ahead of initial expectations due mainly to growth in China label and English label IMF."

Mr Bortolussi also revealed that the company has seen an improvement in trajectory in the ANZ reseller/daigou channel and that he is "confident in the long-term China infant milk formula market."

All in all, this appears to have sparked hopes that the company is now over the worst of its issues. Time will tell if that is the case.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended A2 Milk. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Earnings Results

A happy male investor turns around on his chair to look at a friend while a laptop runs on his desk showing share price movements
Earnings Results

ANZ share price on watch amid first-half earnings beat and $2b buyback

The banking giant appears to have outperformed expectations during the half.

Read more »

A smiling businessman in the city looks at his phone and punches the air in celebration of good news.
Earnings Results

Westpac shares charge higher on half-year earnings beat and buyback

Investors are loving this bank's half-year results release. But why?

Read more »

Contented looking man leans back in his chair at his desk and smiles.
Earnings Results

Westpac share price on watch amid results, special dividend and $1b buyback

This banking giant is rewarding its shareholders handsomely this half.

Read more »

Two happy excited friends in euphoria mood after winning in a bet with a smartphone in hand.
Technology Shares

Why is the Block share price rocketing 10% on Friday?

This payments company outperformed expectations during the first quarter.

Read more »

Two male ASX 200 analysts stand in an office looking at various computer screens showing share prices
Earnings Results

Macquarie share price tumbles on FY24 profit crunch

It certainly was a tough year for the investment bank. Let's see what happened.

Read more »

Happy man at an ATM.
Bank Shares

NAB shares on watch following half-year results and $1.5b buyback

How did this big four bank perform during the half?

Read more »

Group of Imugene scientists cheering in the lab after the company received another patent for HER-Vaxx
Healthcare Shares

3 ASX healthcare shares outperforming on quarterly updates

These stocks are charging ahead on an otherwise lacklustre trading day.

Read more »

A smiling businessman in the city looks at his phone and punches the air in celebration of good news.
Healthcare Shares

ResMed share price jumps 10% on strong quarterly update

ResMed has impressed the market with its third-quarter update.

Read more »